首页> 美国卫生研究院文献>Advances in Medicine >Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium
【2h】

Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium

机译:人心房中丝氨酸/苏氨酸磷酸酶及其抑制剂的年龄依赖性蛋白表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heart failure and aging of the heart show many similarities regarding hemodynamic and biochemical parameters. There is evidence that heart failure in experimental animals and humans is accompanied and possibly exacerbated by increased activity of protein phosphatase (PP) 1 and/or 2A. Here, we wanted to study the age-dependent protein expression of major members of the protein phosphatase family in human hearts. Right atrial samples were obtained during bypass surgery. Patients (n=60) were suffering from chronic coronary artery disease (CCS 2-3; New York Heart Association (NYHA) stage 1–3). Age ranged from 48 to 84 years (median 69). All patients included in the study were given β-adrenoceptor blockers. Other medications included angiotensin-converting enzyme (ACE) or angiotensin-receptor-1 (AT1) inhibitors, statins, nitrates, and acetylsalicylic acid (ASS). 100 µg of right atrial homogenates was used for western blotting. Antibodies against catalytic subunits (and their major regulatory proteins) of all presently known cardiac serine/threonine phosphatases were used for antigen detection. In detail, we studied the expression of the catalytic subunit of PP1 (PP1c); I1PP1 and I2PP1, proteins that can inhibit the activity of PP1c; the catalytic subunit of PP2A (PP2Ac); regulatory A-subunit of PP2A (PP2AA); regulatory B56α-subunit of PP2A (PP2AB); I1PP2A and I2PP2A, inhibitory subunits of PP2A; catalytic and regulatory subunits of calcineurin: PP2BA and PP2BB; PP2C; PP5; and PP6. All data were obtained within the linear range of the assay. There was a significant decline in PP2Ac and I2PP2A expression in older patients, whereas all other parameters remained unchanged with age. It remains to be elucidated whether the decrease in the protein expression of I2PP2A might elevate cardiac PP2A activity in a detrimental way or is overcome by a reduced protein expression and thus a reduced activity of PP2Ac.
机译:心力衰竭和心脏衰老在血液动力学和生化参数方面显示出许多相似之处。有证据表明,实验动物和人类的心力衰竭伴随着蛋白磷酸酶(PP)1和/或2A活性的增加,并可能加剧。在这里,我们想研究人类心脏中蛋白质磷酸酶家族主要成员的年龄依赖性蛋白质表达。在搭桥手术期间获得了右心房样本。患者(n = 60)患有慢性冠状动脉疾病(CC​​S 2-3;纽约心脏协会(NYHA)1-3期)。年龄从48岁到84岁(中位数69岁)不等。纳入研究的所有患者均接受了β-肾上腺素受体阻滞剂。其他药物包括血管紧张素转换酶(ACE)或血管紧张素受体1(AT1)抑制剂,他汀类药物,硝酸盐和乙酰水杨酸(ASS)。 100μg右心房匀浆用于蛋白质印迹。目前所有已知的心脏丝氨酸/苏氨酸磷酸酶的催化​​亚基(及其主要调节蛋白)的抗体都用于抗原检测。详细地,我们研究了PP1(PP1c)催化亚基的表达。 I1 PP1 和I2 PP1 ,它们可以抑制PP1c的活性。 PP2A的催化亚基(PP2Ac); PP2A的调节性A亚基(PP2AA); PP2A(PP2AB)的B56α调节亚基; I1 PP2A 和I2 PP2A ,PP2A的抑制亚基;钙调神经磷酸酶的催化​​和调节亚基:PP2BA和PP2BB; PP2C; PP5;和PP6。所有数据均在测定的线性范围内获得。老年患者的PP2Ac和I2 PP2A 表达显着下降,而所有其他参数均随年龄保持不变。 I2 PP2A 的蛋白表达下降是否可能以有害的方式升高心脏PP2A活性或通过蛋白表达的下降从而克服PP2Ac的活性被克服而尚待阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号